XML 12 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Statements of Operations (unaudited) (USD $)
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Revenue:    
Revenue from licensing agreements and grants$ 41,265$ 123,693$ 162,614$ 409,092
Revenue from product sales182,321129,826516,536318,831
Total revenue223,586253,519679,150727,923
Cost of product sales60,50135,914167,390104,538
Gross profit163,085217,605511,760623,385
Operating expenses:    
Research and development4,524,3345,200,61215,103,84515,096,354
Selling, general and administrative1,733,2292,017,8725,912,2206,889,292
Wind-down expenses68,694 258,749291,168
Total operating expenses6,326,2577,218,48421,274,81422,276,814
Loss from operations(6,163,172)(7,000,879)(20,763,054)(21,653,429)
Other income (expense):    
Realized gain on sale of marketable securities  83,750 
Change in fair value of warrant liability1,697,1941,227,5856,500,3775,184,304
Interest income3,51410,91111,33224,814
Interest expense(16,585)(22,221)(56,585)(72,775)
Other income (expense)144,697232,348107,400230,408
Total other income (expense), net1,828,8201,448,6236,646,2745,366,751
Net loss$ (4,334,352)$ (5,552,256)$ (14,116,780)$ (16,286,678)
Basic and diluted net loss per share*$ (0.31)[1]$ (0.44)[1]$ (1.02)[1]$ (1.33)[1]
Shares used to compute basic and diluted loss per share*14,009,341[1]12,709,172[1]13,831,749[1]12,201,532[1]
[1] Adjusted for the 1-for-10 reverse stock split as discussed in Note 1